Recent relevant studies have also confirmed that DNA methylation in MIR142 promoter can be recognized as a novel biomarker for T cell lymphoma (Sandoval et al., 2015). The gene discussed is MIR142; the disease is T-cell non-Hodgkin lymphoma.